Explore / Clinical trial
Clinical trial

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)

Polaryx Therapeutics, Inc.Not yet recruitingPhase 2Started Dec 1, 202624 enrolledNCT07740512

Abstract

The purpose of this study is to evaluate the safety, tolerability and clinical activity of PLX-200 in pediatric patients with lysosomal storage disorders.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

LSD

Keywords

CLN3CLN2Krabbe DiseasePediatricLysosomal Storage DisordersSandhoff DiseaseKrabbe DiseaseCLN2CLN3

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.